Eizaburo “Sabu” Sasatomi, M.D., Ph.D.

  • Associate Professor of Pathology & Laboratory Medicine, School of Medicine

Biography

Eizaburo “Sabu” Sasatomi, MD, PhD, a specialist in GI and Liver Pathology. Dr. Sasatomi has extensive experience in academic medicine and most recently served as the Director of Liver Pathology at University of North Carolina at Chapel Hill. Before his anatomic pathology residency at the University of Pittsburgh Medical Center (UPMC), he worked for over three years as a postdoctoral fellow in their division of molecular anatomic pathology, using microdissection-based genotyping of human cancers as the principal method of molecular genetic analysis. His current research interests include the correlation of morphological and molecular features with outcome in patients with hepatobiliary and pancreatic neoplasms and the mechanism and diagnosis of chemotherapy-induced liver injury. 

Education

  • M.D., 1989, Saga Medical School
  • Residency:

    • Anatomic Pathology Residency, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, 2003-2006
  • Fellowship:

    • Division of Liver and Transplantation Fellowship, Pathology University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, 2006-2007
    • Molecular Anatomic Pathology Fellowship, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, 2000-2003

Memberships and associations

  • Anatomic Pathology (American Board of Pathology), 2006

Publications

Elsevier pure profile

Selected publications

  • Johnson SM, McGinty KA, Hayashi PH, Sasatomi E. Large Cell Change in a Small Liver: A Histological Clue to Short Telomere Syndromes? Hepatology. 2020 Dec;72(6):2231-2234. 
  • Moreno Prats M, Sasatomi E, Stevenson HL. Colorectal Liver Metastases: A Pathologist's Guide to Creating an Informative Report and Improving Patient Care. Arch Pathol Lab Med. 2019 Feb;143(2):251-257.
  • Law JR, Lee S, Sasatomi E, Bookhout CE, Blatt J. Hepatocellular Carcinoma, Virilization, and Hilus Cell Hyperplasia in a Girl With Turner Syndrome. J Endocr Soc. 2018;2(5):471-475. 
  • French JB, Sasatomi E, Gangarosa LM. Ipilimumab-Nivolumab Combination Therapy Leading to Biopsy Proven Immune Mediated Pancreatitis. J Case Rep Images Med. 2017;3:46–49. 
  • Runge TM, Hart PA, Sasatomi E, Baron TH. Diagnosis of autoimmune pancreatitis using new, flexible EUS core biopsy needles: report of 2 cases. Gastrointest Endosc. 2017 Jun;85(6):1311-1312.
  • Shah ND, Sasatomi E, Baron TH. Acute and Relapsing Hepatitis Caused by Glycogenic Hepatopathy. Clin Gastroenterol Hepatol. 2017 Feb 9. pii: S1542-3565(17)30148-9. doi: 10.1016/j.cgh.2017.02.004. 
  • Shah ND, Sasatomi E, Baron TH. Endoscopic Ultrasound-guided Parenchymal Liver Biopsy: Single Center Experience of a New Dedicated Core Needle. Clin Gastroenterol Hepatol. 2017 May;15(5):784-786. 
  • Stevenson HL, Prats MM, Sasatomi EChemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis. BMC Cancer. 2017 Jan 7;17(1):35. 
  • Kaminsky P, Preiss J, Sasatomi E, Gerber DA. Biliary Adenofibroma: A Rare Hepatic Lesion with Malignant Features. Hepatology. 2017 Jan;65(1):380-383. 
  • Haque T, Sasatomi E, Hayashi PH. Drug Induced Liver Injury: Pattern Recognition and Future Directions. Gut Liver. 2016 Jan;10(1):27-36

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}